indebtedness (i.e., previous term loan debt), to pay fees, costs,
and expenses incurred in connection with entering into the Loan
Agreement, and for working capital purposes.
Upon entering into the Loan Agreement, Xcel paid a 1.75% closing
fee to FEAC for the benefit of the Lenders; the Company also paid
approximately $0.5 million of various legal and other fees in
connection with the execution of the Loan Agreement. These fees and
costs totaling approximately $0.97 million were deferred on the
Company’s balance sheet as of December 31, 2021 as a reduction of
the carrying value of the Term Loan, and commencing in 2022 were
being amortized to interest expense over the term of the Term Loan
using the effective interest method.
The New Term Loan was to mature on April 14, 2025. Principal on the
New Term Loan was payable in quarterly installments of $625,000 on
each of March 31, June 30, September 30 and December 31 of each
year, commencing on March 31, 2022 and ending on March 31, 2025,
with a final payment of $20,875,000 due on the maturity date of
April 14, 2025.
Under the Loan Agreement, Xcel had the right upon
thirty (30) days prior written notice to prepay all
or any portion of the Term Loan and accrued and unpaid interest
thereon. Based on the terms of the Loan Agreement, when the Term
Loan was repaid in full on May 31, 2022, Xcel was required to pay a
prepayment premium of five percent (5.00%), which amounted to
approximately $1.4 million.
For the current quarter and prior year quarter, the Company
incurred interest expense (including both interest paid in cash and
the amortization of deferred finance costs) related to term loan
debt of approximately $0.48 million and $0.52 million,
respectively. The effective interest rate related to term loan debt
was approximately 9.8% and 9.0% for the current quarter and prior
year quarter, respectively.
For the current six months and prior year six months, the Company
incurred interest expense (including both interest paid in cash and
the amortization of deferred finance costs) related to term loan
debt of approximately $1.19 million and $0.80 million,
respectively. The effective interest rate related to term loan debt
was approximately 9.8% and 7.8% for the current quarter and prior
year quarter, respectively.
8. Stockholders’
Equity
Equity Incentive Plans
The Company’s 2021 Equity Incentive Plan (the “2021 Plan”) is
designed and utilized to enable the Company to provide its
employees, officers, directors, consultants, and others whose past,
present, and/or potential contributions to the Company have been,
are, or will be important to the success of the Company, an
opportunity to acquire a proprietary interest in the Company. A
total of 4,000,000 shares of common stock are eligible for issuance
under the 2021 Plan. The 2021 Plan provides for the grant of any or
all of the following types of awards: stock options (incentive or
non-qualified), restricted stock, restricted stock units,
performance awards, or cash awards. The 2021 Plan is administered
by the Company’s Board of Directors, or, at the Board’s discretion,
a committee of the Board.
In addition, stock-based awards (including options, warrants, and
restricted stock) previously granted under the Company’s 2011
Equity Incentive Plan (the “2011 Plan”) remain outstanding and
shares of common stock may be issued to satisfy options or warrants
previously granted under the 2011 Plan, although no new awards may
be granted under the 2011 Plan.